UBS ASSET MANAGEMENT AMERICAS LLC - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 75 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q2 2022$1,115,367,000
-54.9%
291,981
-25.5%
0.00%0.0%
Q1 2022$2,473,546,000
-63.3%
392,004
-32.7%
0.00%
-66.7%
Q4 2021$6,734,335,000
-1.3%
582,555
-4.5%
0.00%0.0%
Q3 2021$6,824,188,000
-51.9%
609,847
+18.1%
0.00%
-50.0%
Q2 2021$14,186,770,000516,2580.01%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Revelation Capital Management, LLC 2,219,951$14,008,00051.22%
ARCH Venture Management, LLC 3,798,926$23,971,0003.43%
Tikvah Management LLC 707,600$4,465,0001.43%
Triatomic Management LP 221,708$1,399,0001.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,612,019$41,722,0000.93%
Perceptive Advisors 3,655,207$23,064,0000.46%
Casdin Capital, LLC 1,442,870$9,105,0000.41%
Orbimed Advisors 2,300,792$14,518,0000.24%
Nicholas Investment Partners, LP 519,885$3,280,0000.23%
Alphabet Inc. 586,584$3,701,0000.12%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders